Issue link: https://nebusinessmedia.uberflip.com/i/1535455
sevenhills.org Seven Hills Salutes Seven Hills Salutes Dr. Kathleen Jordan Dr. Kathleen Jordan and Winners of the and Winners of the WBJ Power 100 WBJ Power 100 Dr. Kathleen M. Jordan, President & CEO of Seven Hills Foundation & Affiliates, empowers her dedicated workforce to Answer the Call to Care with Seven Hills' Core Values of Respect & Kindness, Integrity, Teamwork, Innovation, and Service to Others. From the front lines of direct support to overdose intervention, Dr. Jordan navigates the complexities of Health and Human Services with the foresight to advance Seven Hills' continuum of supports to the next level of excellence and positive outcomes. Thank you, Dr. Jordan, for your leadership and dedication to the optimal well-being for people of all abilities in our communities. wbjournal.com | May 19, 2025 | Worcester Business Journal 13 L I F E S C I E N C E S P OW E R 1 0 0 Protecting Worcester's Business Leaders Coverage That Works as Hard as You Do gaudette-insurance.com 508-234-6333 At Gaudette Insurance, we're committed to protecting the businesses that power our community. 5 Offices to Service You Westborough | Shrewsbury | Grafton | Southborough | Whitinsville Jochen Salfeld Head of R&D Cures, vice president, virology discovery research AbbVie, in Worcester Employees: 55,000 globally Residence: Grafton College: Heidelberg University in Germany In his 35 years with AbbVie, Salfeld has been personally involved in growing a small startup in a leased space in Cambridge into a biopharmaceutical powerhouse. irty years ago, he was in charge of the team of scientists that invented the blockbuster drug Humira. In Worcester, AbbVie's 553,000-square-foot bioresearch center has research and development and manufacturing colleagues working alongside each other. e collaborative environment leads to cross-functional learning, which Salfeld said is important for pharmaceutical development, which involves trial and error and production at scale. Right now, he's particularly proud of his involvement leading the company's Pathway to Cures initiative, focused on de- fining cures for its core therapeutic areas and assessing how they can happen. e idea is to dream big, and move beyond making incremental improvements to curing disease. AbbVie, headquartered in Illinois, reported global net revenues of $13.3 bil- lion in the first quarter of 2025, compared to $12.3 billion for the same period in 2024. e company's largest revenue driver was its immunology portfolio, generating $6.3 billion, compared to neuroscience ($2.3 billion), oncology ($1.6 billion), and aesthetics ($1.1 billion). Net earnings dipped from $1.4 billion to $1.3 billion in the first quarter as well. And Salfeld remains its man on the ground in Worcester, leading innovation for a company dedicated to making the world healthier. - L.F.